FDA Issues Early Communication For Chantix « Weight Loss | Dieting Tips | Weight Loss Advice | Free Tips

FDA Issues Early Communication For Chantix

FDA is evaluating postmarketing adverse event reports for Chantix (varenicline), a prescription medicine to help adults stop smoking.

This entry was posted on Thursday, November 22nd, 2007 at 8:10 pm and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

You must be logged in to post a comment.

Weight Loss | Dieting Tips | Weight Loss Advice | Free Tips | Europe

FDA Issues Early Communication For Chantix

Leave a Reply